Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: Mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release

British Journal of Pharmacology

Volumn 117, Issue 4, 1996, Pages 595-606

  Clarke, P B S ^a   Reuben, M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Acetylcholine; Chlorisondamine; Dihydro erythroidine; Dopamine; Nicotine; Noradrenaline

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; ACETYLCHOLINE; ANATOXIN A; CHLORISONDAMINE; CITALOPRAM; CYTISINE; DIHYDRO BETA ERYTHROIDINE; DOPAMINE; LOBELINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR; NORADRENALIN; POTASSIUM ION; RECEPTOR SUBTYPE; VERATRIDINE; ALKALOID; AZOCINE DERIVATIVE; BACTERIAL TOXIN; CYANOBACTERIAL TOXIN; CYANOGINOSIN; MARINE TOXIN; NICOTINIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT; POTASSIUM; QUINOLIZINE DERIVATIVE; SEROTONIN ANTAGONIST; TETRODOTOXIN; TRITIUM;

ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG INHIBITION; HIPPOCAMPUS; MALE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SYNAPTOSOME; ANIMAL; CLASSIFICATION; DRUG EFFECT; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACETYLCHOLINE; ALKALOIDS; ANIMALS; AZOCINES; BACTERIAL TOXINS; CITALOPRAM; CORPUS STRIATUM; HIPPOCAMPUS; MALE; MARINE TOXINS; MICROCYSTINS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; NOREPINEPHRINE; POTASSIUM; QUINOLIZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SEROTONIN ANTAGONISTS; SYNAPTOSOMES; TETRODOTOXIN; TRITIUM;

EID: 0029670671     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15232.x     Document Type: Article

References (88)

1. AIZENMAN, E., TANG, L.-H. & REYNOLDS, LJ. (1991). Effects of nicotinic agonists on the NMDA receptor. Brain Res., 551, 355-357.
2. ALKONDON, M. & ALBUQUERQUE, E.X. (1993). Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther., 265, 1455-1473.
3. ALKONDON, M., PEREIRA, E.F.R., WONNACOTT, S. & ALBUQUERQUE, E.X. (1992). Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol. Pharmacol., 41, 802-808.
4. ARQUEROS, L., NAQUIRA, D. & ZUNINO, E. (1978). Nicotine-induced release of catecholamines from rat hippocampus and striatum. Biochem. Pharmacol., 27, 2667-2674.
5. ASTON-JONES, G., SHIPLEY, M.T. & GRZANNA, R. (1995). The locus coeruleus, A5 and A7 noradrenergic cell groups. In The Rat Nervous System, ed. Paxinos, G. pp. 183-213. New York: Academic Press, edn. 2.
6. 14C-5-hydroxytyramine by rat brain homogenates. Eur. J. Pharmacol., 23, 19-26.
7. BHAT, R.V., TURNER, S.L., SELVAAG, S.R., MARKS, M.J. & COLLINS, A.C. (1991). Regulation of brain nicotinic receptors by chronic agonist infusion. J. Neurochem., 56, 1932-1939.
8. BROWN, D.A. (1980). Locus and mechanism of action of ganglion-blocking agents. Handb. Exp. Pharmacol., 53, 185-235.
9. BUCCAFUSCO, J.J., JACKSON, W.J., GATTU, M. & TERRY, A.V. (1995). Isoarecolone-induced enhancement of delayed matching to sample performance in monkeys: role of nicotinic receptors. NeuroReport, 6, 1223-1227.
10. CACHELIN, A.B. & JAGGI, R. (1991). β Subunits determine the time course of desensitization in rat α3 neuronal nicotinic acetylcholine receptors. Pflügers Arch., 419, 579-582.
11. CACHELIN, A.B. & RUST, G. (1994). Unusual pharmacology of (+)-tubocurarine with rat neuronal nicotinic acetylcholine receptors containing β4 subunits. Mol. Pharmacol., 46, 1168-1174.
12. CACHELIN, A.B. & RUST, G. (1995). β-subunits co-determine the sensitivity of rat neuronal nicotinic receptors to antagonists. Pflügers Arch., 429, 449-451.
13. CAULFIELD, M.P & HIGGINS, G.A. (1983). Mediation of nicotine-induced convulsions by central nicotinic receptors of the 'C6' type. Neuropharmacology, 22, 347-351.
14. CLARKE, P.B.S., CHAUDIEU, J., EL-BIZRI, H., BOKSA, P., QUIK, M., ESPLIN, B.A. & CAPEK, R. (1994a). The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion. Br. J. Pharmacol., 111, 397-405.
15. CLARKE, P.B.S. & PERT, A. (1985). Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res., 348, 355-358.
16. CLARKE, P.B.S. & REUBEN, M. (1995a). Pharmacological comparison of nicotine-evoked release of striatal dopamine and hippocampal noradrenaline from superfused synaptosomes. Soc. Neurosci. Abstr., 21, 721-729.
17. +: Possible action at the dopamine transporter. Br. J. Pharmacol., 114, 315-322.
18. CLARKE, P.B.S., REUBEN, M. & EL-BIZRI, H. (1994b). Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum. Br. J. Pharmacol., 111, 695-702.
19. COLLINS, A.C., EVANS, C.B., MINER, L.L. & MARKS, M.J. (1986). Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors. Pharmacol. Biochem. Behav., 24, 1767-1773.
20. COLQUHOUN, L., DINELLEY, K & PATRICK, J. (1993). A hetero-beta neuronal nicotinic acetylcholine receptor expressed in Xenopus oocytes. Soc. Neurosci. Abstr., 19, 1533.
21. CONNOLLY, J., BOULTER, J. & HEINEMANN, S.F. (1992). α4-2β2 And other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs. Br. J. Pharmacol., 105, 657-666.
22. CONROY, W.G. & BERG, D.K. (1995). Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J. Biol. Chem., 270, 4424-4431.
23. 2) transfected into mouse fibroblasts with ion channel activity. Brain Res., 667, 118-122.
24. COVERNTON, P.J.O., KOJIMA, H., SIVILOTTI, L.G., GIBB, A.J. & COLQUHOUN, D. (1994). Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in Xenopus oocytes. J. Physiol., 481, 27-34.
25. DAR, M.S., LI, C. & BOWMAN, E.R. (1993). Central behavioral interactions between ethanol, (-)-nicotine, and (-)-cotinine in mice. Brain Res. Bull., 32, 23-28.
26. DINELEY-MILLER, K. & PATRICK, J. (1992). Gene transcripts for the nicotinic acetylcholine receptor subunit, beta4, are distributed in multiple areas of the rat central nervous system. Brain. Res. Mol. Brain Res., 16, 339-344.
27. DRASDO, A., CAULFIELD, M., BERTRAND, D., BERTRAND, S. & WONNACOTT, S. (1992). Methyllycaconitine: a novel nicotinic antagonist. Mol. Cell. Neurosci., 3, 237-243.
28. DUNNETT, C.W. (1995). A multiple comparison procedure for comparing several treatments with a control. J. Am. Statist. Assoc., 50, 1096-1121.
29. EL-BIZRI, H. & CLARKE, P.B.S. (1994). Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br. J. Pharmacol., 111, 406-413.
30. FLORES, C.M., ROGERS, S.W., PABREZA, L.A., WOLFE, B.B. & KELLAR, K.J. (1992). A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol., 41, 31-37.
31. FUDALA, P.J. & IWAMOTO, E.T. (1986). Further studies on nicotine-induced conditioned place preference in the rat. Pharmacol. Biochem. Behav., 25, 1041-1049.
32. GLANTZ, S.A. (1992). Primer of Biostatistics. New York: McGraw-Hill. 3rd edn.
33. 3H]dopamine release from mouse striatal synaptosomes. J. Neurochem., 62, 1390-1398.
34. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem., 59, 848-856.
35. HOLBACH, H.J., LINDMAR, R. & LOFFELHOLZ, K. (1977). DMPP and the adrenergic nerve terminal: mechanisms of noradrenaline release from vesicular and extravesicular compartments. Naunyn Schmied. Arch. Pharmacol., 300, 131-138.
36. HYTTEL, J. (1994). Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int. Clin. Psychopharmacol., 9 Suppl. 1, 19-26.
37. 3H]dopamine release in rat striatum. J. Neurochem., 56, 603-610.
38. KHAN, I.M., TAYLOR, P. & YAKSH, T.L. (1994). Cardiovascular and behavioral responses to nicotinic agents administered intrathecally. J. Pharmacol. Exp. Ther., 270, 150-158.
39. 3H](-)-nicotine binding in rat cortex. Neuropharmacology, 32, 847-853.
40. LUETJE, C.W. & PATRICK, J. (1991). Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci., 11, 837-845.
41. LUETJE, C.W., PIATTONI, M. & PATRICK, J. (1993). Mapping of ligand binding sites of neuronal nicotinic acetylcholine receptors using chimeric α subunits. Mol. Pharmacol., 44, 657-666.
42. LUETJE, C.W., WADA, K., ROGERS, S., ABRAMSON, S.N., TSUJI, K., HEINEMANN, S. & PATRICK, J. (1990). Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J. Neurochem., 55, 632-640.
43. MANDELZYS, A., DE KONINCK, P. & COOPER, E. (1995). Agonist and toxin sensitivities of ACh-evoked currents on neurons expressing multiple nicotinic ACh receptor subunits. J. Neurophysiol., (in press).
44. MANDELZYS, A., PIÉ, B., DENERIS, E.S. & COOPER, E. (1994). The developmental increase in ACh current densities on rat sympathetic neurons correlates with changes in nicotinic ACh receptor α-subunit gene expression and occurs independent of innervation. J. Neurosci., 14, 2357-2364.
45. MARKS, M.J. & COLLINS, A.C. (1982). Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Mol. Pharmacol., 22, 554-564.
46. MARKS, M.J., FARNHAM, D.A., GRADY, S.R. & COLLINS, A.C. (1993). Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J. Pharmacol. Exp. Ther., 264, 542-552.
47. MITCHELL, S.N. (1993). Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine. Neuropharmacology, 32, 937-949.
48. MULLE, C., VIDAL, C., BENOIT, P. & CHANGEUX, J.P. (1991). Existence of different subtypes of nicotinic acetylcholine receptors in the rat habenulo-interpeduncular system. J. Neurosci., 11, 2588-2597.
49. OLNEY, J.W., PRICE, M.T., LABYUYERE, J., SHAHID SALLES, K., FRIEDRICH, G., MULLER, M. & SILVERMAN, E. (1987). Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur. J. Pharmacol., 142, 319-320.
50. PAPKE, R.L. (1993). The kinetic properties of neuronal nicotinic receptors: Genetic basis of functional diversity. Prog. Neurobiol., 41, 509-531.
51. PAPKE, R.L., DUVOISIN, R.M. & HEINEMANN, S.F. (1993). The amino terminal half of the nicotinic β-subunit extracellular domain regulates the kinetics of inhibition by neuronal bungarotoxin. Proc. R. Soc. B., 252, 141-148.
52. PAPKE, R.L. & HEINEMANN, S.F. (1994). Partial agonist properties of cytisine on neuronal nicotinic receptors containing the β2 subunit. Mol. Pharmacol., 45, 142-149.
53. PITTALUGA, A. & RAITERI, M. (1992). N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J. Pharmacol. Ther., 260, 232-237.
54. RAPIER, C., LUNT, G.G. & WONNACOTT, S. (1988). Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J. Neurochem., 50, 1123-1130.
55. 3H-dopamine release from striatal synaptosomes: pharmacological characterisation. J. Neurochem., 54, 937-945.
56. REAVILL, C., SPIVAK, C.E., STOLERMAN, I.P. & WATERS, J.A. (1987). Isoarecolone can inhibit nicotine binding and produce nicotine-like discriminative stimulus effects in rats. Neuropharmacology, 26, 789-792.
57. REAVILL, C., WALTHER, B., STOLERMAN, I.P. & TESTA, B (1990a). Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology, 29, 619-624.
58. REAVILL, C., WATERS, J.A., STOLERMAN, I.P. & GARCHA, H.S. (1990b). Behavioural effects of the nicotinic agonists N-(3-pyridylmethyl)pyrrolidine and isoarecolone in rats. Psychopharmacology, 102, 521-528.
59. ROMANO, C. (1981). Nicotine action on rat colon. J. Pharmacol. Exp. Ther., 217, 828-833.
60. ROMANO, C., GOLDSTEIN, A. & JEWELL, N.P. (1981). Characterization of the receptor mediating the nicotine discriminative stimulus. Psychopharmacology, 74, 310-315.
61. ROWELL, P.P. & HILLEBRAND, J.A. (1994). Characterization of nicotine-induced desensitization of evoked dopamine release from rat striatal synaptosomes. J. Neurochem., 63, 561-569.
62. ROWELL, P.P. & WONNACOTT, S. (1990). Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes. J. Neurochem., 55, 2105-2110.
63. RUST, G., BURGUNDER, J.-M., LAUTERBURG, T.E. & CACHELIN, A.B. (1994). Expression of neuronal nicotinic acetylcholine receptor subunit genes in the rat autonomic nervous system. Eur. J. Neurosci., 6, 478-485.
64. SACAAN, A.I., DUNLOP, J.L. & LLOYD, G.K. (1995). Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. Exp. Ther., 274, 224-230.
65. SAKURAI, Y., TAKANO, Y., KOHJIMOTO, Y., HONDA, K. & KAMIYA, H.O. (1982). Enhancement of 3Hdopamine release and its 3Hmetabolites in rat striatum by nicotinic drugs. Brain Res., 242, 99-106.
66. SCHMIDT, J. (1977). Drug binding properties of an alpha-bungarotoxin-binding component from rat brain. Mol. Pharmacol., 13, 283-290.
67. SCHULZ, D.W. & ZIGMOND, R.E. (1989). Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum. Neurosci. Lett., 98, 310-316.
68. SCHWARTZ, R.D. & KELLAR, K.J. (1983). [3H]Acetylcholine binding sites in brain: effect of disulphide bond modification. Mol. Pharmacol., 24, 387-391.
69. 3H-acetylcholine on catecholamine and serotonin axons in brain. J. Neurochem., 42, 1495-1498.
70. 7: A nicotinic cation channel highly permeable to calcium. J. Neurosci., 13, 596-604.
71. SNELL, L.D. & JOHNSON, K.M. (1989). Effects of nicotinic agonists and antagonists on N-methyl-D-aspartate-induced 3H-norepinephrine release and 3H-(1-1-(2-thienyl)cyclohexyl-piperidine) binding in rat hippocampus. Synapse, 3, 129-135.
72. 3H]dopamine release from rat striatal synaptosomes. Neuropharmacology, (in press).
73. STOLERMAN, I.P., ALBUQUERQUE, E.X. & GARCHA, H.S. (1992). Behavioural effects of anatoxin, a potent nicotinic agonist, in rats. Neuropharmacology, 31, 311-314.
74. STOLERMAN, I.P., GARCHA, H.S. & MIRZA, N.R. (1995). Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology (Berl), 117, 430-437.
75. SWANSON, K.L., ARONSTAM, R.S., WONNACOTT, S., RAPOPORT, H. & ALBUQUERQUE, E.X. (1992). Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites. J. Pharmacol. Exp. Ther., 259, 377-386.
76. THOMAS, P., STEPHENS, M., WILKIE, G., AMAR, M., LUNT, G.G., WHITING, P., GALLAGHER, T., PEREIRA, E., ALKONDON, M., ALBUQUERQUE, E.X. & WONNACOTT, S. (1993). (+)-anatoxin-a is a potent agonist at neuronal nicotinic acetylcholine receptors. J. Neurochem., 60, 2308-2311.
77. VERNALLIS, A.B., CONROY, W.G. & BERG, D.K. (1993). Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit segregation among receptor subtypes. Neuron, 10, 451-464.
78. VIDAL, C. & CHANGEUX, J.-P. (1993). Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro. Neuroscience, 56, 23-32.
79. WADA, E., MCKINNON, D., HEINEMANN, S., PATRICK, J. & SWANSON, L.W. (1990). The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (alpha 5) in the rat central nervous system. Brain Res., 526, 45-53.
80. WADA, E., WADA, K., BOULTER, J., DENERIS, E., HEINEMANN, S., PATRICK, J. & SWANSON, L.W. (1989). Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol., 284, 314-335.
81. WARD, J.M., COCKCROFT, V.B., LUNT, G.G., SMILLIE, F.S. & WONNACOTT, S. (1990). Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sites. FEBS Lett., 270, 45-48.
82. WEAVER, W.R., WOLF, K.M. & CHIAPPINELLI, V.A. (1994). Functional heterogeneity of nicotinic receptors in the avian lateral spiriform nucleus detected with trimethaphan. Mol. Pharmacol., 46, 993-1001.
83. WHITEAKER, P., GARCHA, H.S., WONNACOTT, S. & STOLERMAN, I.P. (1995). Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats. Br. J. Pharmacol., (in press).
84. WHITING, P.J. & LINDSTROM, J.M. (1988). Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J. Neurosci., 8, 3395-3403.
85. WILLIAMS, M. & ROBINSON, J.L. (1984). Binding of the nicotinic cholinergic antagonist, dihydro-beta-erythroidine, to rat brain tissue. J. Neurosci., 4, 2906-2911.
86. 4, expressed in transfected eucaryotic cells. Brain Res. Mol. Brain Res., 28, 101-109.
87. WONNACOTT, S., JACKMAN, S., SWANSON, K.L., RAPOPORT, H. & ALBUQUERQUE, E.X. (1992). Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic binding sites. J. Pharmacol. Exp. Ther., 259, 387-391.
88. ZOLI, M., LE NOVERE, N., HILL, J.A., JR. & CHANGEUX, J.-P. (1995). Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J. Neurosci., 15, 1912-1939.